Industry Insights

  1. Patient Recruitment Versus Enrollment In Clinical Trial Rescue Studies 2/19/2026

    Recovering a clinical trial requires more than just outreach; it demands a clear strategy to bridge the gap between initial patient interest and final enrollment to restore study momentum.

  2. Time Is Lives: How Collaboration And Urgency Are Rewriting The Future Of Rare Disease 2/19/2026

    The inflection point has arrived, says Rob Freishtat, MD, MPH. Understand how collaboration will rewrite how we think of rare disease clinical research.

  3. The Problem With Excluding Children From GLP-1 Trials In The U.S. 2/19/2026

    In the U.S., roughly 15 million children are obese. But many are excluded from GLP-1 research. Obesity expert Evan Nadler, MD, explains why that's problematic.

  4. 5 Projections For 2026: Navigating The New Normal In Clinical Trials 2/18/2026

    In 2026, clinical trial success depends on moving from AI hype to proven utility. Unified data and seamless site experiences are no longer optional; they are the keys to trial resilience.

  5. Shaping The Future Of Clinical Trial Technology With tPlatform Unification 2/18/2026

    As we look toward 2026, the conversation around clinical trial technology is shifting from simple digitization to true platform unification.

  6. Rethinking Technology For Patients And Sites In Clinical Trials 2/18/2026

    The solution to administrative burden in clinical trials is not in adding more tools, but in improved integration that allows software to fade into the background.

  7. What The Suvoda-Greenphire Merger Means For Clinical Trials 2/18/2026

    Simplify the clinical trial journey by unifying logistics, data, and payments. Reduce administrative friction for sites and improve the patient experience to accelerate trial timelines.

  8. SCOPE 2026 In The Rear-View Mirror 2/18/2026

    Another SCOPE Summit is in the record books, and it was jam-packed with informative sessions. Themes included patient-centricity, AI (no surprise here), patient recruitment, and much more.

  9. U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact 2/18/2026

    Beroe Inc.'s Mathini Ilancheran discusses the 2025 U.S. pharma tariff framework and translates it into actionable procurement and outsourcing responses.

  10. How One Market Signal Reframed AI's Value In Early BioTech 2/17/2026

    Explore how transparent decision-making and operational integrity are redefining value for early-stage life science ventures, navigating the path from discovery to market.